Aligos Therapeutics, Inc.
ALGS$5.34▲ 3.89% 24h
Aligos Therapeutics, Inc.ALGS$5.34
+$0.2138(+4.17%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$203.68M
P/E ratio
—
EPS (diluted)
$-2.45
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$2.19M
Net income
$-24.19M
Net margin
-1106.7%
Gross margin
—
Dividends & financials
Aligos Therapeutics, Inc. (ALGS) reported revenue of $2.19M and net income of $-24.19M, or $-2.45 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.